Alvotech (ALVO) Gains from Investment Securities (2021 - 2025)
Alvotech (ALVO) reported Gains from Investment Securities of -$322000.0 for Q3 2025, down 61.81% on a YoY basis from -$843131.6 in Q3 2024, and down 411.11% quarter-over-quarter from -$63000.0 in Q2 2025.
Alvotech (ALVO) Gains from Investment Securities (2021 - 2025) Analysis & Trends
Alvotech has reported Gains from Investment Securities for 5 years, with the latest figure at -$322000.0 in Q3 2025.
- For the quarter ending Q3 2025, Gains from Investment Securities fell 61.81% year-over-year to -$322000.0; the trailing twelve-month figure through Sep 2025 stood at -$2.6 million (down 35.48% YoY), and the FY2023 full-year result was -$1.4 million, down 62.35% from the prior year.
- Gains from Investment Securities for Q3 2025 stood at -$322000.0, down from -$63000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $171000.0 in Q4 2021, with the low at -$2.0 million in Q4 2024.
- Historically, Gains from Investment Securities has averaged -$435428.6 across 5 years, with a median of -$186000.0 in 2024.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities sank 587.72% — and 2025, when it jumped 66.13%.
- Alvotech's Gains from Investment Securities stood at $171000.0 in 2021, then slumped by 587.72% to -$834000.0 in 2022, then slumped by 62.35% to -$1.4 million in 2023, then tumbled by 50.44% to -$2.0 million in 2024, then jumped by 84.19% to -$322000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$322000.0 (Q3 2025), -$63000.0 (Q2 2025), and -$186000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Alvotech | 12.20 Mn | -160.16 Mn | -22.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -322,000.00 |
| Sep 30, 2025 | -322,000.00 |
| Jun 30, 2025 | -63,000.00 |
| Jun 30, 2025 | -63,000.00 |
| Mar 31, 2025 | -186,000.00 |
| Mar 31, 2025 | -186,000.00 |
| Dec 31, 2024 | -2.04 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Sep 30, 2024 | -199,000.00 |
| Sep 30, 2024 | -199,000.00 |
| Jun 30, 2024 | -186,000.00 |
| Jun 30, 2024 | -186,000.00 |
| Mar 31, 2024 | -186,000.00 |
| Mar 31, 2024 | -186,000.00 |
| Dec 31, 2023 | -1.35 Mn |
| Dec 31, 2023 | -1.35 Mn |
| Jun 30, 2023 | -536,000.00 |
| Jun 30, 2023 | -536,000.00 |
| Mar 31, 2023 | -116,000.00 |
| Mar 31, 2023 | -116,000.00 |